Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214589 · ClinicalTrials.gov registry record · NA
Non-pharmacological Interventions for Procedural Pain in Premature Neonates
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT02214589 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 203 participants.
The verdict
NCT02214589, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
A. Specific Aims Premature infants admitted to the neonatal intensive care unit (NICU) require up to several hundred procedures during their hospitalization. Many of these are tissue-damaging procedures (TDPs) known to cause pain \[1\]. Through funding from NINR, the investigators found that TDPs not only caused pain but also increased markers of ATP degradation and oxidative stress\[2\[. The TDP was tape removal, a commonly performed procedure in the NICU2. Based on this finding, the investigators sought to determine if interventions that relieve pain also reduce biochemical markers of ATP degradation and oxidative stress. The investigators first examined the effect of oral sucrose, a commonly used intervention, when given before a heel lance. The investigators chose heel lance because it is the most predominant painful procedure in the NICU, as shown in 29 different clinical trials\[3\]. The investigators hypothesized that since oral sucrose is documented to significantly reduce pain scores, then administration of this analgesic will also decrease markers of ATP degradation and oxidative stress. However,the investigators observed the opposite effect. Although a single dose of oral sucrose reduced behavioral markers of pain, it significantly increased biochemical markers of ATP degradation (hypoxanthine, uric acid) and oxidative stress (allantoin) over time\[4\]. More importantly, the effect of oral sucrose on breakdown markers of ATP were enhanced and were significantly higher in neonates that were intubated or were receiving more than 30% FiO25. These findings lead to the question: If oral sucrose does not effectively reduce the biochemical effects of procedural pain, what intervention or groups of intervention will decrease both behavioral markers of procedural pain and reduce ATP utilization and oxidative stress in premature neonates? For this RO1 renewal, the investigators propose to test the individual and additive effects of two commonly used interventions
Interventions
- OTHER Oral glucose, facilitated tucking, NNS
- OTHER Oral glucose and NNS
- OTHER Facilitated tucking and NNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02214589
The ClinicalTrials.gov registry entry for NCT02214589 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Oral glucose, facilitated tucking, NNS is the first listed.
NCT02214589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02214589 about?
NCT02214589 is a clinical study titled "Non-pharmacological Interventions for Procedural Pain in Premature Neonates". A. Specific Aims Premature infants admitted to the neonatal intensive care unit (NICU) require up to several hundred procedures during their hospitalization. Many of these are tissue-damaging procedures (TDPs) known to cause pain \[1\]. Through funding from NINR, the investigators found that TDPs no...
What is the current status of trial NCT02214589?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2014-08. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02214589?
The interventions under investigation include: Oral glucose, facilitated tucking, NNS (OTHER), Oral glucose and NNS (OTHER), Facilitated tucking and NNS (OTHER).
Who is sponsoring clinical trial NCT02214589?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.